IONSHealthcareLarge-Cap
IONIS PHARMACEUTICALS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for IONIS PHARMACEUTICALS INC (IONS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are IONS insiders buying or selling?
IONIS PHARMACEUTICALS INC insiders reported 2 open-market buys ($659.0K) and 308 sells ($309.7M) across 310 Form 4 filings — a net selling position of $309.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 9, 2026)
Total Form 4 filings
310
SEC EDGAR
Insider filers
24
Insider buys (2)
$659.0K
Insider sells (308)
$309.7M
Insider sentiment
Net sellingNet insider flow of $309.1M in net selling.
Recent IONS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sale | 20.5K | $84.95 | $1.7M |
| Jul 9, 2026 | Allene M. Diaz | Director | Sale | 10.1K | $85.42 | $863.6K |
| Jul 9, 2026 | Holly B. Kordasiewicz | EVP, Chief Development Officer | Sale | 362 | $84.30 | $30.5K |
| Jul 6, 2026 | Joseph Klein III | Director | Sale | 11.5K | $79.04 | $910.4K |
| Jun 30, 2026 | Joseph Baroldi | EVP, Chief Business Officer | Sale | 5.6K | $80.16 | $451.7K |
| Jun 30, 2026 | Patrick R. O'Neil | EVP CLO & General Counsel | Sale | 3.1K | $80.00 | $245.5K |
| Jun 30, 2026 | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Sale | 26.0K | $81.05 | $2.1M |
| Jun 26, 2026 | Brett P Monia | Chief Executive Officer | Sale | 85.6K | $79.70 | $6.8M |
| Jun 26, 2026 | Eric Swayze | EVP Research | Sale | 10.6K | $79.18 | $839.5K |
| Jun 16, 2026 | Holly B. Kordasiewicz | EVP, Chief Development Officer | Sale | 60.8K | $73.41 | $4.5M |
| Jun 16, 2026 | BERTHELSEN SPENCER R | Director | Sale | 8.0K | $73.49 | $587.9K |
| Jun 3, 2026 | BERTHELSEN SPENCER R | Director | Sale | 8.0K | $75.67 | $605.4K |
| May 15, 2026 | Brett P Monia | Chief Executive Officer | Sale | 4.5K | $78.49 | $356.0K |
| May 6, 2026 | Joseph Loscalzo | Director | Sale | 77.3K | $75.06 | $5.8M |
| May 5, 2026 | Joseph Klein III | Director | Sale | 10.1K | $73.51 | $743.2K |
| Apr 30, 2026 | Joseph Baroldi | EVP, Chief Business Officer | Sale | 1.6K | $71.79 | $116.7K |
| Apr 17, 2026 | Lynne B Parshall | Director | Sale | 5.0K | $76.27 | $381.4K |
| Apr 17, 2026 | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Sale | 4.9K | $75.17 | $368.5K |
| Apr 17, 2026 | Brian Birchler | EVP, Corp and Development Ops | Sale | 973 | $75.04 | $73.0K |
| Apr 17, 2026 | Joseph Baroldi | EVP, Chief Business Officer | Sale | 5.6K | $74.56 | $419.0K |
| Apr 2, 2026 | Joseph Klein III | Director | Sale | 22.3K | $75.55 | $1.7M |
| Apr 2, 2026 | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale | 6.2K | $74.05 | $458.6K |
| Mar 23, 2026 | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Sale | 5.8K | $70.97 | $412.5K |
| Mar 18, 2026 | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sale | 225.2K | $72.43 | $16.3M |
| Mar 11, 2026 | Patrick R. O'Neil | EVP CLO & General Counsel | Sale | 10.1K | $75.25 | $763.7K |
Showing the 25 most recent of 310 Form 4 filings for IONIS PHARMACEUTICALS INC.
Most active IONS insiders
- Brett P Monia40 filings
- Patrick R. O'Neil32 filings
- BENNETT C FRANK26 filings
- Eric Swayze24 filings
- Richard S Geary23 filings
Ask anything about IONS insider activity
Use Trabud's AI agent to query IONIS PHARMACEUTICALS INC's Form 4 history in plain English — "Show me IONS CEO purchases this year" or compare it against any other ticker.
Open the AI agentIONS insider trading FAQ
Are IONIS PHARMACEUTICALS INC insiders buying or selling?
Across 310 SEC Form 4 filings, IONIS PHARMACEUTICALS INC (IONS) insiders reported 2 open-market purchases totaling $659.0K and 308 sales totaling $309.7M. That is a net selling position of $309.1M.
How many insiders trade IONS stock?
24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for IONIS PHARMACEUTICALS INC. The most recent filing was accepted on Jul 9, 2026.
Where does Trabud get IONS insider trading data?
All IONS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.